[Influence on atherosclerosis of improvement of bone mineral density after medication for osteoporosis].
作者信息
Yamada Shinsuke, Inaba Masaaki, Nishizawa Yoshiki
机构信息
Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine.
出版信息
Nihon Rinsho. 2007 Nov 28;65 Suppl 9:348-51.
PMID:18161129
Abstract
摘要
相似文献
1
[Influence on atherosclerosis of improvement of bone mineral density after medication for osteoporosis].
Nihon Rinsho. 2007 Nov 28;65 Suppl 9:348-51.
2
[New development in bisphosphonate treatment. Review of effect on bone metabolism by minodronic acid in primary osteoporosis].
Clin Calcium. 2009 Jan;19(1):63-73.
3
[New bone density conservation agents for osteoporosis under research and development: ED-71].
Nihon Rinsho. 2007 Nov 28;65 Suppl 9:454-8.
4
[New bone density conservation agents for osteoporosis under research and development: Strontium ranelate].
Nihon Rinsho. 2007 Nov 28;65 Suppl 9:447-53.
5
Bisphosphonates in the treatment of osteoporosis.
BMJ. 2012 May 22;344:e3211. doi: 10.1136/bmj.e3211.
6
[New therapy using bisphosphonate for urolithiasis].
Clin Calcium. 2011 Oct;21(10):1511-5.
7
[Diagnosis, clinical feature and treatment of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis].
Nihon Rinsho. 2007 Nov 28;65 Suppl 9:499-503.
8
[Alendronate].
Clin Calcium. 2008 Oct;18(10):1410-6.
9
[Evidence of alendronate treatment for osteoporosis].
Nihon Rinsho. 2007 Nov 28;65 Suppl 9:337-43.
10
Effect of alendronate on bone mineral density in Puerto Rican males with osteoporosis.
P R Health Sci J. 2005 Jun;24(2):131-5.
Zotero 插件